{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:09:13Z","timestamp":1719792553960},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,30]]},"DOI":"10.7759\/cureus.63500","type":"journal-article","created":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T10:17:33Z","timestamp":1719742653000},"source":"Crossref","is-referenced-by-count":0,"title":["Association of Lipoprotein and Apolipoprotein Ratios With Glycemic Levels in Individuals With Prediabetes: A Case-Control Study"],"prefix":"10.7759","author":[{"given":"Sherwan","family":"Salih","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.8774","article-title":"Risk of progression to diabetes among older adults with prediabetes","volume":"181","author":"Rooney MR","year":"2021","unstructured":"Rooney MR, Rawlings AM, Pankow JS, Echouffo Tcheugui JB, Coresh J, Sharrett AR, Selvin E. Risk of progression to diabetes among older adults with prediabetes. JAMA Intern Med. 2021, 181:511-9. 10.1001\/jamainternmed.2020.8774","journal-title":"JAMA Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2017.10.003","article-title":"Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome","volume":"42 Suppl 1","author":"Punthakee Z","year":"2018","unstructured":"Punthakee Z, Goldenberg R, Katz P. Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can J Diabetes. 2018, 42 Suppl 1:S10-5. 10.1016\/j.jcjd.2017.10.003","journal-title":"Can J Diabetes"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph13020235","article-title":"Appropriate LDL-C-to-HDL-C ratio cutoffs for categorization of cardiovascular disease risk factors among Uygur adults in Xinjiang, China","volume":"13","author":"Chen QJ","year":"2016","unstructured":"Chen QJ, Lai HM, Chen BD, et al.. Appropriate LDL-C-to-HDL-C ratio cutoffs for categorization of cardiovascular disease risk factors among Uygur adults in Xinjiang, China. Int J Environ Res Public Health. 2016, 13:235. 10.3390\/ijerph13020235","journal-title":"Int J Environ Res Public Health"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.923797","article-title":"Lipoprotein(a) in cardiovascular diseases: insight from a bibliometric study","volume":"10","author":"\u0160uran D","year":"2022","unstructured":"\u0160uran D, Bla\u017eun Vo\u0161ner H, Zavr\u0161nik J, et al.. Lipoprotein(a) in cardiovascular diseases: insight from a bibliometric study. Front Public Health. 2022, 10:923797. 10.3389\/fpubh.2022.923797","journal-title":"Front Public Health"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.25271\/sjuoz.2023.11.1.996","article-title":"Lipoprotein(a) level among patients with type 2 diabetes mellitus and prediabetes in comparison with healthy controls","volume":"11","author":"Abdullah BI","year":"2023","unstructured":"Abdullah BI, Salih SF. Lipoprotein(a) level among patients with type 2 diabetes mellitus and prediabetes in comparison with healthy controls. Sci J Univ Zakho. 2023, 11:30-6. 10.25271\/sjuoz.2023.11.1.996","journal-title":"Sci J Univ Zakho"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11100690","article-title":"Apolipoprotein B and cardiovascular disease: biomarker and potential therapeutic target","volume":"11","author":"Behbodikhah J","year":"2021","unstructured":"Behbodikhah J, Ahmed S, Elyasi A, Kasselman LJ, De Leon J, Glass AD, Reiss AB. Apolipoprotein B and cardiovascular disease: biomarker and potential therapeutic target. Metabolites. 2021, 11:690. 10.3390\/metabo11100690","journal-title":"Metabolites"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b15-00716","article-title":"Metabolism and modification of apolipoprotein B-containing lipoproteins involved in dyslipidemia and atherosclerosis","volume":"39","author":"Morita SY","year":"2016","unstructured":"Morita SY. Metabolism and modification of apolipoprotein B-containing lipoproteins involved in dyslipidemia and atherosclerosis. Biol Pharm Bull. 2016, 39:1-24. 10.1248\/bpb.b15-00716","journal-title":"Biol Pharm Bull"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081097","article-title":"Apolipoprotein A-I (ApoA-I), immunity, inflammation and cancer","volume":"11","author":"Georgila K","year":"2019","unstructured":"Georgila K, Vyrla D, Drakos E. Apolipoprotein A-I (ApoA-I), immunity, inflammation and cancer. Cancers (Basel). 2019, 11:1097. 10.3390\/cancers11081097","journal-title":"Cancers (Basel)"},{"key":"ref9","article-title":"Lipoprotein metabolism in nonalcoholic fatty liver disease","volume":"27","author":"Jiang ZG","year":"2013","unstructured":"Jiang ZG, Robson SC, Yao Z. Lipoprotein metabolism in nonalcoholic fatty liver disease. J Biomed Res. 2013, 27:1-13.","journal-title":"J Biomed Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-38014-3","article-title":"Apolipoprotein A-I enhances insulin-dependent and insulin-independent glucose uptake by skeletal muscle","volume":"9","author":"Tang S","year":"2019","unstructured":"Tang S, Tabet F, Cochran BJ, Cuesta Torres LF, Wu BJ, Barter PJ, Rye KA. Apolipoprotein A-I enhances insulin-dependent and insulin-independent glucose uptake by skeletal muscle. Sci Rep. 2019, 9:1350. 10.1038\/s41598-018-38014-3","journal-title":"Sci Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-023-01860-w","article-title":"Association of apolipoproteins and lipoprotein(a) with metabolic syndrome: a systematic review and meta-analysis","volume":"22","author":"Ulloque-Badaracco JR","year":"2023","unstructured":"Ulloque-Badaracco JR, Al-Kassab-C\u00f3rdova A, Hernandez-Bustamante EA, et al.. Association of apolipoproteins and lipoprotein(a) with metabolic syndrome: a systematic review and meta-analysis. Lipids Health Dis. 2023, 22:98. 10.1186\/s12944-023-01860-w","journal-title":"Lipids Health Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/43.9.1622","article-title":"Multicenter evaluation of a homogeneous assay for HDL-cholesterol without sample pretreatment","volume":"43","author":"Nauck M","year":"1997","unstructured":"Nauck M, Ma\u0308rz W, Jarausch J, et al.. Multicenter evaluation of a homogeneous assay for HDL-cholesterol without sample pretreatment. Clin Chem. 1997, 43:1622-9. 10.1093\/clinchem\/43.9.1622","journal-title":"Clin Chem"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/bios12090738","article-title":"Electrochemiluminescence systems for the detection of biomarkers: strategical and technological advances","volume":"12","author":"Yoo SM","year":"2022","unstructured":"Yoo SM, Jeon YM, Heo SY. Electrochemiluminescence systems for the detection of biomarkers: strategical and technological advances. Biosensors (Basel). 2022, 12:10.3390\/bios12090738","journal-title":"Biosensors (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101934","article-title":"Development and validation of an insulin resistance model for a population without diabetes mellitus and its clinical implication: a prospective cohort study","volume":"58","author":"Tsai SF","year":"2023","unstructured":"Tsai SF, Yang CT, Liu WJ, Lee CL. Development and validation of an insulin resistance model for a population without diabetes mellitus and its clinical implication: a prospective cohort study. EClinicalMedicine. 2023, 58:101934. 10.1016\/j.eclinm.2023.101934","journal-title":"EClinicalMedicine"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2018.030708","article-title":"Evaluation of the analytical performances of the Cobas c513 analyser for HbA(1c) assay","volume":"28","author":"Jaisson S","year":"2018","unstructured":"Jaisson S, Leroy N, Soulard M, Desmons A, Guillard E, Gillery P. Evaluation of the analytical performances of the Cobas c513 analyser for HbA(1c) assay. Biochem Med (Zagreb). 2018, 28:030708. 10.11613\/BM.2018.030708","journal-title":"Biochem Med (Zagreb)"},{"key":"ref16","article-title":"Prediabetes","author":"Alvarez S","year":"2017","unstructured":"Alvarez S, Coffey R, Algotar AM. Prediabetes. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2017."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i5953","article-title":"Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis","volume":"355","author":"Huang Y","year":"2016","unstructured":"Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ. 2016, 355:i5953. 10.1136\/bmj.i5953","journal-title":"BMJ"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1370\/afm.1946","article-title":"Prevalence of prediabetes and abdominal obesity among healthy-weight adults: 18-year trend","volume":"14","author":"Mainous AG 3rd","year":"2016","unstructured":"Mainous AG 3rd, Tanner RJ, Jo A, Anton SD. Prevalence of prediabetes and abdominal obesity among healthy-weight adults: 18-year trend. Ann Fam Med. 2016, 14:304-10. 10.1370\/afm.1946","journal-title":"Ann Fam Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-012-0419-9","article-title":"Association of the apolipoprotein B\/apolipoprotein A-I ratio and low-density lipoprotein cholesterol with insulin resistance in a Chinese population with abdominal obesity","volume":"49","author":"Ying X","year":"2012","unstructured":"Ying X, Qian Y, Jiang Y, Jiang Z, Song Z, Zhao C. Association of the apolipoprotein B\/apolipoprotein A-I ratio and low-density lipoprotein cholesterol with insulin resistance in a Chinese population with abdominal obesity. Acta Diabetol. 2012, 49:465-72. 10.1007\/s00592-012-0419-9","journal-title":"Acta Diabetol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/MJBL.MJBL_269_22","article-title":"Triglyceride glucose index, its modified indices, and triglyceride HDL-C ratio as predictor markers of insulin resistance in prediabetic individuals","volume":"20","author":"Suleiman RR","year":"2023","unstructured":"Suleiman RR, Salih SF, Abdullah BI, Ibrahim IH, Saeed ZA. Triglyceride glucose index, its modified indices, and triglyceride HDL-C ratio as predictor markers of insulin resistance in prediabetic individuals. Med J Babylon. 2023, 20:268-73. 10.4103\/MJBL.MJBL_269_22","journal-title":"Med J Babylon"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-014038","article-title":"Associations of apolipoprotein B\/apolipoprotein A-I ratio with pre-diabetes and diabetes risks: a cross-sectional study in Chinese adults","volume":"7","author":"Zheng S","year":"2017","unstructured":"Zheng S, Han T, Xu H, et al.. Associations of apolipoprotein B\/apolipoprotein A-I ratio with pre-diabetes and diabetes risks: a cross-sectional study in Chinese adults. BMJ Open. 2017, 7:e014038. 10.1136\/bmjopen-2016-014038","journal-title":"BMJ Open"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2018.12.022","article-title":"Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study","volume":"282","author":"Saeed A","year":"2019","unstructured":"Saeed A, Sun W, Agarwala A, et al.. Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study. Atherosclerosis. 2019, 282:52-6. 10.1016\/j.atherosclerosis.2018.12.022","journal-title":"Atherosclerosis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2022.11.007","article-title":"Elevated ApoB\/ApoA-\u0399 ratio is associated with poor outcome in acute ischemic stroke","volume":"107","author":"Li Z","year":"2023","unstructured":"Li Z, Zhang D, Song Z, et al.. Elevated ApoB\/ApoA-\u0399 ratio is associated with poor outcome in acute ischemic stroke. J Clin Neurosci. 2023, 107:138-43. 10.1016\/j.jocn.2022.11.007","journal-title":"J Clin Neurosci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1210\/js.2017-00472","article-title":"Vitamin D supplementation, glycemic control, and insulin resistance in prediabetics: a meta-analysis","volume":"2","author":"Mirhosseini N","year":"2018","unstructured":"Mirhosseini N, Vatanparast H, Mazidi M, Kimball SM. Vitamin D supplementation, glycemic control, and insulin resistance in prediabetics: a meta-analysis. J Endocr Soc. 2018, 2:687-709. 10.1210\/js.2017-00472","journal-title":"J Endocr Soc"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2006.01643.x","article-title":"The apoB\/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence","volume":"259","author":"Walldius G","year":"2006","unstructured":"Walldius G, Jungner I. The apoB\/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence. J Intern Med. 2006, 259:493-519. 10.1111\/j.1365-2796.2006.01643.x","journal-title":"J Intern Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/cdn\/nzaa160","article-title":"The effect of inflammation and insulin resistance on lipid and lipoprotein responsiveness to dietary intervention","volume":"4","author":"Petersen KS","year":"2020","unstructured":"Petersen KS, Bowen KJ, Tindall AM, Sullivan VK, Johnston EA, Fleming JA, Kris-Etherton PM. The effect of inflammation and insulin resistance on lipid and lipoprotein responsiveness to dietary intervention. Curr Dev Nutr. 2020, 4:nzaa160. 10.1093\/cdn\/nzaa160","journal-title":"Curr Dev Nutr"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000222015.76038.14","article-title":"Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans","volume":"26","author":"Duez H","year":"2006","unstructured":"Duez H, Lamarche B, Uffelman KD, Valero R, Cohn JS, Lewis GF. Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans. Arterioscler Thromb Vasc Biol. 2006, 26:1357-63. 10.1161\/01.ATV.0000222015.76038.14","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2013.04.001","article-title":"The regulation of ApoB metabolism by insulin","volume":"24","author":"Haas ME","year":"2013","unstructured":"Haas ME, Attie AD, Biddinger SB. The regulation of ApoB metabolism by insulin. Trends Endocrinol Metab. 2013, 24:391-7. 10.1016\/j.tem.2013.04.001","journal-title":"Trends Endocrinol Metab"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.311912","article-title":"The vasculature in prediabetes","volume":"122","author":"Wasserman DH","year":"2018","unstructured":"Wasserman DH, Wang TJ, Brown NJ. The vasculature in prediabetes. Circ Res. 2018, 122:1135-50. 10.1161\/CIRCRESAHA.118.311912","journal-title":"Circ Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/265061-association-of-lipoprotein-and-apolipoprotein-ratios-with-glycemic-levels-in-individuals-with-prediabetes-a-case-control-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T10:17:37Z","timestamp":1719742657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/265061-association-of-lipoprotein-and-apolipoprotein-ratios-with-glycemic-levels-in-individuals-with-prediabetes-a-case-control-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,30]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.63500","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,30]]}}}